Author: Canadian Drug Policy Coalition

  • Medications and clinical approaches to support physical distancing for PWUD

    Medications and clinical approaches to support physical distancing for PWUD

    physical distancing for people who use drugs, physical distancing for people who use drugs


    Click HERE for more resources

    “This document is one in a series of six national guidance documents, developed rapidly by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, a significant number of works were consulted in drafting this guidance; a list of works consulted is provided in Appendix 1: Works Consulted on page 31.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local public health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Supporting people who use drugs in acute care settings during COVID-19

    Supporting people who use drugs in acute care settings during COVID-19

    supporting people who use drugs in acute care, supporting people who use drugs in acute care


    Click HERE for more resources

    “This document is one of a series of six national guidance documents, rapidly developed by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use drugs, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, when available, scientific evidence is cited in support of the expert advice offered herein.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local Public Health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Reducing COVID-19 Spread in Recovery Programs & Treatment Services

    Reducing COVID-19 Spread in Recovery Programs & Treatment Services

    reducing COVID-19 transmission in recovery and treatment programs, reducing COVID-19 transmission in recovery and treatment programs


    Click HERE for more resources

    “This document is one in a series of six national guidance documents, developed rapidly by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local public health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Telemedicine support for addiction services

    Telemedicine support for addiction services

    telemedicine support for addiction services, telemedicine support for addiction services


    Click HERE for more resources

    “This document is one of a series of six national guidance documents, rapidly developed by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, when available, scientific evidence is cited in support of the expert advice offered herein.

    The guidance provided in this document is subject to change as new information becomes available. Readers should note that the intent of this document is to provide general guidance rather than detailed procedural and logistical advice. Readers are advised to consult local public health and medical authorities for specific input on navigating their own unique regulatory and policy environments, as necessary.”

    Source: CRISM

  • Expanded Response Options to Opioid Harms: Case Study from Four Cities

    Expanded Response Options to Opioid Harms: Case Study from Four Cities

    CCSA case study, CCSA case study

    Click HERE for more resources

    “Canada is facing an urgent challenge to reduce the harms associated
    with the problematic use of opioids. More than 14,700 lives were lost to deaths apparently related to opioids between January 2016 and September 2019. During that same period, there were 19,490 hospitalizations for poisoning related opioid to opioids (Special Advisory Committee on the Epidemic of Opioid Overdoses, 2019). The COVID-19 pandemic compounds this ongoing public health crisis. There is a heightened need to reduce avoidable pressures on healthcare systems and support people who use opioids who may be at increased risk or unable to self-isolate during the pandemic.”

    Source: Canadian Centre on Substance Use

  • Harm Reduction and COVID-19 Guidance for Service Providers

    Harm Reduction and COVID-19 Guidance for Service Providers

    Alberta health services covid guidance, Alberta health services covid guidance


    Click HERE for more resources

    “This guidance document for community service providers was prepared by the Alberta Health Services (AHS) Harm Reduction Services Team in partnership with the Alberta Community Council on HIV (ACCH). It covers information on how community services may alter harm reduction practices during the COVID-19 pandemic with the goal of reducing the spread of COVID-19. This information can also be used by service providers to communicate information and education on reducing spread of COVID-19 while maintaining health and wellness along the spectrum of substance use.”

  • Decriminalizing drugs and the path towards defunding police

    Decriminalizing drugs and the path towards defunding police

    With global protests igniting around the killing of George Floyd in Minneapolis, calls to defund police are growing louder. For some, this may seem like an extreme proposition, but as the history of drug policy in Canada and globally has shown, the criminalization of drugs—and millions poured into police budgets to enforce associated laws—have fueled some of the greatest harms to society.

    This interview by Black Lives Matter Toronto co-founder, Sandy Hudson, articulates the clear logic around defunding police and what that means: reallocated funds more intelligently and eliminating from police control those roles they are now performing that cause serious community-level harm, and getting other more capable organizations to carry out those activities. Social development is key to creating healthier and safer communities. We believe it would make society safer by reallocating resources into vital social programs—like housing and employment services—that would do a better job in creating safety for everyone.

    The significant resources pouring into enforcing inhumane drug laws that criminalize the possession of controlled substances for personal use is one of many areas in the purview of police that should be defunded. There is a mountain of evidence showing that criminalizing people who use drugs is extremely harmful. Currently amidst the COVID-19 pandemic, the criminalization of drugs forces people to consume substances in isolation and engage in survival strategies that increase their risk of fatal overdose.

    The millions we spend on criminalizing drug use could instead be funnelled into harm reduction and drug treatment programs that have been proven to save lives and build community, rather than fuel harm. Police themselves have said that they “cannot arrest their way out of the overdose crisis.” The cost in taxpayer dollars, but more importantly human lives, could be reduced by moving away from policing in this area as has been done in other countries.

    (Photo credit: Peter Kim | National Day of Action on the Overdose Crisis | 2018)

    BC’s chief medical health officer, Dr. Bonnie Henry, recently lauded for her pandemic response by the New York Times, has called for the decriminalization of drugs. And this policy shift has been echoed by other leading health experts across Canada. This same shrinking of scope and defunding of budgets is possible in other areas of policing where public health and safety are being adversely impacted by police involvement, such as mental health calls.

    The amazing efforts and courage of Black-led advocacy groups have pushed this issue to the forefront of our collective consciousness at a time when the world is on the cusp of transformative change. In addition to amplifying the messages and calls for change of the #BlackLivesMatter movement, we can play an important role by supporting its efforts on the ground to ensure this pivotal moment in history bends towards justice.

    Please consider donating to Black Lives Matter Toronto or the Black Legal Action Centre to ensure the movement for change continues. 

    Stimulus Connect #3 is happening June 26. RSVP here.

    Drug decriminalization and defunding the police Drug decriminalization and defunding the police Drug decriminalization and defunding the police

  • ‘Safer opioid distribution’ as an essential public health intervention for opioid mortality crisis

    ‘Safer opioid distribution’ as an essential public health intervention for opioid mortality crisis

    safer opioid distribution as public health intervention safer opioid distribution as public health intervention

    Click HERE for more resources

    Highlights:

    • Canada experiences excessive opioid mortality, mainly from toxic opioid exposure.
    • Many interventions have been implemented, but are limited in reach and impact.
    • ‘Safer opioid distribution’ (SOD) is a crucial preventive measure for overdose.
    • SOD needs to be implemented for a large, ‘at-risk’ opioid user population.
    • Other community-based public health interventions may guide SOD organization.

    Source: https://www.sciencedirect.com/science/article/pii/S266653522030015X?via%3Dihub

  • Supporting people who use drugs in shelter settings during COVID‐19

    Supporting people who use drugs in shelter settings during COVID‐19

    supporting people who use drugs in shelters supporting people who use drugs in shelters


    Click HERE for more resources


    “This document is one of a series of six national guidance documents, rapidly developed by the CRISM network at the request of the Government of Canada. Collectively, the six documents address urgent needs of people who use substances, service providers, and decision makers in relation to the COVID-19 pandemic. The urgent nature of this work required rapid development and dissemination of this guidance. This, and the continuing evolution of the knowledge base regarding COVID-19, precluded CRISM from conducting a comprehensive review of the relevant literature. However, when available, scientific evidence is cited in support of the expert advice offered herein.”

    Source: CRISM